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Breast self-examination (BSE) is widely recommended for breast cancer prevention. Following recent controversy over the efficacy of
mammography, it may be seen as an alternative. We present a meta-analysis of the effect of regular BSE on breast cancer mortality.
From a search of the medical literature, 20 observational studies and three clinical trials were identified that reported on breast cancer
death rates or rates of advanced breast cancer (a marker of death) according to BSE practice. A lower risk of mortality or advanced
breast cancer was only found in studies of women with breast cancer who reported practising BSE before diagnosis (mortality:
pooled relative risk 0.64, 95% CI 0.56–0.73; advanced cancer, pooled relative risk 0.60, 95% CI 0.46–0.80). The results are probably
due to bias and confounding. There was no difference in death rate in studies on women who detected their cancer during an
examination (pooled relative risk 0.90, 95% CI 0.72–1.12). None of the trials of BSE training (in which most women reported
practising it regularly) showed lower mortality in the BSE group (pooled relative risk 1.01, 95% CI 0.92–1.12). They did show that
BSE is associated with considerably more women seeking medical advice and having biopsies. Regular BSE is not an effective method
of reducing breast cancer mortality.
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For many years, women have been taught methods of breast self-
examination (BSE) and it is recommended that they practise this
regularly (Boyle et al, 1995; Shapiro et al, 1998), usually every
month. There is a belief that among women who practise BSE,
those who develop breast cancer are more likely to find it at an
earlier stage and this is expected to lead to earlier treatment and
hence decrease their risk of dying from the disease. Breast self-
examination is appealing as a routine screening method because
the examination has no financial cost (apart from the initial
instruction sessions) and can be conducted in private. Most studies
on the effectiveness of BSE have been observational. They suggest
that women who practise BSE are more likely to find their breast
tumour themselves, that the tumour tends to be smaller and that
these women have an increased survival (Hackshaw, 1996;
International Agency for Research on Cancer (IARC), 2002).
However, survival time as an outcome measure can be misleading
because of lead-time bias, in which BSE only identifies cancers at
an earlier stage but has no effect on prognosis. Using mortality
rates instead of survival time can overcome much of this bias.
Recently, the International Agency for Research on Cancer
(2002) published a review on breast-cancer screening that reported
the individual results from observational studies of BSE in relation
to survival and stage of cancer, and those from randomised trials
and cohort studies in relation to mortality. We here, however,
present a meta-analysis of BSE and breast-cancer mortality by
reviewing the published evidence from both observational studies
and randomised trials, including those based on women with
advanced breast cancer (used as a marker of death), and pooling
the results. We look at three aspects of BSE; women who practise
BSE, women who find their cancer during one of their regular
examinations, and women who are taught BSE and advised to
practise it regularly.
METHODS
Data sources and study selection
Studies that reported on rates of death from breast cancer or rates
of advanced breast cancer (a marker of death) according to BSE
practice were identified from Medline, Embase and Cancerlit
(1966–2002), and included in the analysis. Keywords used were
‘breast cancer’ with ‘BSE’ or ‘self-examination’. In some studies,
women were classified according to whether they practised BSE
regularly or not. In other studies, women were classified according
to the method of detecting the cancer: during BSE, by chance (e.g.
while washing or dressing), mammography or examination by
physician. Below we describe the main common features of the
studies, but in the interest of brevity we do not provide further
details, since these can be obtained directly from the individual
published reports.
We included results on mortality or, as a surrogate for
death, advanced breast cancer (defined as stage III or IV, regional
or distant). Analyses are presented separately for these two
outcomes.
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Studies on women newly diagnosed with breast cancer A total of
15 studies were based only on women newly diagnosed with breast
cancer (Greenwald et al, 1978; Smith et al, 1980; Feldman
et al, 1981; Tamburini et al, 1981; Foster and Costanza, 1984;
Owen et al, 1985; Smith and Burns, 1985; Ogawa et al,
1987; Huguley et al, 1988; Kuroishi et al, 1992; Le Geyte
et al, 1992; Kurebayashi et al, 1994; Auvinen et al, 1996;
McPherson et al, 1997; Koibuchi et al, 1998) and they were
divided into four groups based on two different measures of
outcome and two different measures of exposure.
  Women who reported practising BSE or not and were then
followed up for several years (usually about 5 years) to see who
later died from breast cancer.
  Women who reported whether they found their cancer during
self-examination or by chance and were then followed up for
several years to see who later died from breast cancer.
  Women found to have advanced breast cancer at the time of
initial diagnosis who reported retrospectively on whether they
practised BSE or not.
  Women found to have advanced breast cancer at the time of
initial diagnosis who reported retrospectively on whether they
had found their cancer during self-examination or by chance
(e.g. washing and dressing).
In most studies mammography use was not stated, although it
would not have been offered to many women since these studies
were based on women diagnosed before the mid-1980s when such
screening was not commonplace. In other studies, mammography
use was low (2% of cancers detected by mammography, in
Feldman et al, 1981) or similar between the BSE and non-BSE
groups (Smith and Burns, 1985). In one study (Koibuchi et al,
1998), all women had a clinical examination as part of a mass-
screening programme. A difference between the BSE and non-BSE
group was reported with respect to mammography use in one
study (18% in the BSE group compared to 7% in the non-BSE
group, Huguley et al, 1988) and mass screening by clinician
examination in another study (37% in the BSE group and 21% in
the non-BSE group, Kuroishi et al, 1992); analyses were performed
both with and without these two studies.
Cohort studies of women with and without breast cancer The two
cohort studies were from Finland (Gastrin et al, 1994) and the USA
(Holmberg et al, 1997). In these, breast cancer death rates
according to BSE practice were reported in populations of women
followed up for over 13 years. In one study (Gastrin et al, 1994),
mammography was used only as a method of further investigation
after a woman found a lump by BSE. In the other study, the follow-
up period was until 1972 when mammography was not common-
place.
Case–control studies of women with and without breast can-
cer There were three case–control studies, two from the USA
(Newcomb et al, 1991; Muscat and Huncharek, 1992) and one from
Canada that was nested within a randomised trial of mammo-
graphy (Harvey et al, 1997). In each study, cases (women who had
died from breast cancer or had advanced cancer) and age-matched
controls (women without breast cancer) were asked about their
past BSE practice. One study also further matched for screening
centre and enrolment year.
Clinical trials One trial, from the UK, was nonrandomised (UK
Trial of Early Detection of Breast Cancer Group, 1999) and two,
from China (Thomas et al, 1997, 2002) and Russia (Semiglazov
et al, 1992, 1996, 1999), were randomised. The nonrandomised trial
was based on comparing the breast cancer death rates after 16
years follow-up in two centres, in which women aged 45–64 years
were invited to attend a BSE session, with the rates in four centres,
in which women were not invited for either BSE training or
mammography.
The two randomised trials were large. The one from China
(Thomas et al, 1997, 2002) was based on randomising 520 factories
in Shanghai, in which all women in a particular factory were either
given three sessions on how to practise BSE or they were not. In
total, there were about 267000 women aged 30–69 years.
Recruitment began in 1989 and interim results were reported after
5 years. The trial in Russia involved two cities (Moscow and St
Petersburg (formerly Leningrad)), but only the results from St
Petersburg have been published; approximately five (Semiglazov
et al, 1992), nine (Semiglazov et al, 1996) and 13 (Semiglazov et al,
1999) years after recruitment began in 1985. This trial included
about 120000 women aged 40–64 years and, similar to the one in
China, randomisation was undertaken according to the place of
work and BSE was taught during several sessions. Information on
the following was also extracted from the reports of the two
randomised trials; the number of women who sought medical
advice after finding a lump, the number who had a biopsy and the
number diagnosed with breast cancer. Mammography screening
was not available to women in either trial.
Attendance of the BSE training sessions in the UK trial was low;
only 31 and 53% of women in the two centers, respectively,
accepted the invitation to be taught BSE. Attendance in the trial
from China was high; 98% received baseline instruction and in one
cohort with complete information on attendance (representing
about half the women in the BSE group in the trial) 84% had
attended all three training sessions. The reports from the Russian
trial were based on women who had received training in BSE.
Definition of BSE practice
In the studies based on only women newly diagnosed with breast
cancer, the definition of BSE practice varied. It was monthly
(Ogawa et al, 1987; Auvinen et al, 1996), monthly or several times a
year (Feldman et al, 1981; Tamburini et al, 1981; Foster and
Costanza, 1984; Koibuchi et al, 1998) or at least two (Smith and
Burns, 1985) or three (Smith et al, 1980) times per year. In several
studies, about half or more of the women in the BSE groups had
reported that they checked their breasts monthly (Feldman et al,
1981; Smith and Burns, 1985; Ogawa et al, 1987; Le Geyte et al,
1992). In the two cohort studies (Gastrin et al, 1994; Holmberg
et al, 1997) women were classified as BSE practitioners, if they did
so monthly. In the Russian trial, 76% of women taught BSE
reported practising it at least every 2 months (Semiglazov et al,
1999), and in the Chinese trial women practised BSE at least every
4–5 months during the first 4–5 years of the trial and were
strongly encouraged to practise it monthly (Thomas et al, 2002).
Statistical analysis
The relative risks (or odds ratio) and 95% confidence intervals
(CI) were estimated from the data in each study. They were
pooled on a log scale and weighted by the inverse of the variance,
with allowance for any heterogeneity (DerSimonian and Laird,
1986).
RESULTS
Table 1 shows results from the observational studies based only on
women with breast cancer.
Figure 1 shows the individual relative risk of death from breast
cancer and the pooled relative risks. Overall, there appears to be a
statistically significant 36% reduction in the risk of death (relative
risk 0.64, 95% CI 0.56–0.73, Po0.001) in those who practise BSE.
There was no evidence of heterogeneity between the studies
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do not and in those who found their cancer during an examination
Women who practise BSE regularly Women who never or rarely practise BSE
Study (first author),
country
Age of women
(years)
No. of breast cancer
deaths or advanced
cancers
No. of women with
breast cancer
No. of breast cancer
deaths or advanced
cancers
No. of women with
breast cancer
Relative risk of death or
advanced cancer
(95% CI)
Breast cancer death
Foster, 1984, USA All (20–97) 61 424 108 411 0.55 (0.40–0.75)
22–49 18 134 15 58 0.52 (0.26–1.03)
50–97 43 287 92 346 0.56 (0.39–0.81)
Huguley, 1988, USA All (unspec.) 327 1398 260 681 0.61 (0.52–0.72)
Le Geyte, 1992, UK 15–59 60 226 130 390 0.80 (0.59–1.08)
Kurebayashi, 1994, Japan All (unspec.) 3 91 10 132 0.44 (0.12–1.58)
Auvinen, 1996, Finland All (unspec.) F 246 F 104 0.85 (0.53–1.33)
Advanced breast cancer
Smith, 1980, USA 30–80 44 107 24 57 0.98 (0.59–1.61)
Feldman, 1981, USA All (unspec.) 137 408 256 588 0.77 (0.63–0.95)
Tamburini, 1981, Italy 35–64 34 170 90 330 0.73 (0.49–1.09)
Foster, 1984, USA All (20–97) 41 422 123 410 0.32 (0.23–0.46)
Smith, 1985, USA 20–54 75 185 67 134 0.81 (0.58–1.13)
Ogawa, 1987, Japan 25–77 3 30 20 116 0.58 (0.17–1.95)
Huguley, 1988, USA All (unspec.) 225 1396 246 680 0.45 (0.37–0.53)
Kurebayashi, 1994, Japan All (unspec.) 7 91 18 132 0.56 (0.24–1.35)
Koibuchi, 1998, Japan All (unspec.) 3 68 18 174 0.43 (0.13–1.45)
Cancer found during BSE Cancer found by accident
a
Breast cancer death
Greenwald, 1978, USA All (unspec.) 16 55 65 182 0.81 (0.47–1.41)
Kuroishi, 1992, Japan All (unspec.) F 347 F 1322 0.57 (0.33–0.99)
Auvinen, 1996, Finland All (unspec.) F 34 F 104 1.06 (0.88–1.26)
McPherson, 1997, USA 40–49 33 200 70 364 0.86 (0.57–1.30)
Advanced breast cancer
Greenwald, 1978, USA All (unspec.) 11 55 56 182 0.65 (0.34–1.24)
Owen, 1985, USA All (unspec.) 76 185 539 1168 0.89 (0.70–1.13)
Kuroishi, 1992, Japan All (unspec.) 28 355 224 1327 0.47 (0.32–0.69)
aIn one study (Greenwald et al, 1978), 20% of women in this group practised BSE although found their cancer by chance. Italics indicate that the data were estimated from results presented in the paper.
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Epidemiology(P¼0.41). If the study in which some women had mammo-
graphy (Huguley et al, 1988) is excluded, the estimate is not
substantially different (relative risk 0.69, 95% CI 0.56–0.85,
Po0.001). In those women who reported that their cancer was
detected during self-examination, there was no evidence of a
reduction in the risk of death compared to those who found their
cancer by chance (relative risk 0.90, 95% CI 0.72–1.12, P¼0.34).
Again there was no strong evidence of heterogeneity between the
results (P¼0.26). If the study (Kuroishi et al, 1992) in which some
women had mass screening is excluded, the estimate is not much
changed the pooled relative risk is 1.00 (95% CI 0.85–1.18,
P¼0.98).
Figure 2 shows the relative risk of having advanced breast cancer
in women who practise BSE compared to those who did
not, among all women newly diagnosed with breast cancer. There
is a 40% reduction in the risk (relative risk 0.60, 95% CI 0.46–0.80,
Po0.001). Although there was evidence of hetero-
geneity (Po0.001), all the studies reported a reduction in risk.
In women who found their cancer during an examination, there
was a 34% reduction in risk (relative risk 0.66, 95% CI 0.44–1.01,
P¼0.06).
The results from the cohort and case–control studies of women
with and without breast cancer according to BSE practice are
shown in Table 2. The two cohort studies show inconsistent
results; one indicates a statistically significant 29% reduction in the
risk of death associated with BSE practice (relative risk 0.71, 95%
CI 0.57–0.87) and the other shows no effect at all (relative risk
1.03, 95% CI 0.95–1.12). The pooled estimate is not statistically
significant (relative risk 0.87, 95% CI 0.62–1.23, P¼0.42). None of
the case–control studies found statistically significant effects with
only one suggesting a benefit (Harvey et al, 1997). The results for
two of the case–control studies were not materially altered after
adjustment for mammography use (Newcomb et al, 1991; Muscat
and Huncharek, 1992).
Table 3 provides the main results from the trials of teaching
BSE and Figure 3 shows the relative risks and the pooled estimates
for the main outcomes. The nonrandomised trial in the UK
showed no effect overall (relative risk 0.99) even after 16 years of
follow-up, although there was a difference between the two BSE
centres; one showing a reduction in mortality (relative risk 0.79)
and the other not (relative risk 1.09), which cannot readily be
explained.
In the Russian trial, twice as many women in the BSE group
sought medical advice compared to the non-BSE group (Figure 2),
and this was consistent throughout the course of the
trial (BSE vs non-BSE groups: 5.6 vs 2.8% at 5 years, 7.2 vs 3.5%
0.2 0.5 1 2 3 4 5
Relative risk of dying from breast
cancer in BSE vs non-BSE groups
0.64 (0.56−0.73)
0.69 (0.56−0.85)
0.90 (0.72−1.12)
1.00 (0.85−1.18)
Practise BSE vs do not practise BSE
Cancer found by BSE vs found by chance
Foster, 1984
Huguley, 1988
Le Geyte, 1992
Kurebayashi, 1994
Auvinen, 1996
All
All (excl. Huguley)
Greenwald, 1978
Kuroishi, 1992
Auvinen, 1996
McPherson, 1997
All
All (excl. Kuroishi)
Figure 1 Observational studies of women with breast cancer, compar-
ing the breast cancer death rates between the BSE and non-BSE groups. A
test for heterogeneity between the studies yielded a P-value of 0.41 for
those studies based on women who practise BSE and a P-value of 0.26 for
those based on finding cancer by BSE.
0.2 0.5 1 2 3 4 5
Relative risk of having advanced 
breast cancer in BSE vs non-BSE groups
Practise BSE vs do not practise BSE
Foster, 1984
Huguley, 1988
Kurebayashi, 1994
All
All
Koibuchi, 1998
Kuroishi, 1992
Greenwald, 1978
Owen, 1985
Ogawa, 1987
Tamburini, 1981
Feldman, 1981
Smith, 1985
Smith, 1980
Cancer found by BSE vs found by chance
0.60 (0.46−0.80)
0.66 (0.44−1.01)
Figure 2 Observational studies of women with breast cancer, compar-
ing the rates of advanced breast cancer between the BSE and non-BSE
groups. A test for heterogeneity between the studies yielded a P-value of
o0.001 for those studies based on women who practise BSE and a P-value
of 0.051 for those based on finding cancer by BSE.
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trials (Russia and China) show that overall there were 53%
more biopsies in women who were taught BSE compared to those
who were not, this was highly statistically significant (relative
risk of having a biopsy 1.53, 95% CI 1.44–1.63, Po0.001).
The trials also suggest that at 5 years, women taught BSE were no
more likely to be diagnosed with breast cancer than those not
taught BSE (relative risk 1.01). After a longer follow-up (9–10
years), there is an indication from the Russian trial that
more cancers were found in the BSE group (24% more women
diagnosed with breast cancer), but this was not found in the trial
from China.
The risk of dying from breast cancer was remarkably consistent
between the three trials and over the different follow-up periods.
There was no evidence of an advantage in the BSE group after any
length of follow-up. The pooled relative risk was 1.01 with narrow
95% confidence limits (0.92–1.12, P¼0.79); there was no evidence
of heterogeneity (P¼0.94). The results were not materially
different if the nonrandomised trial from the UK was excluded,
pooled relative risk 1.05 (95% CI 0.90–1.24, P¼0.54).
Table 2 Observational studies of women with and without breast cancer; number of deaths and relative risk of dying from breast cancer in women who
practise BSE compared to those who do not
Women who practise BSE regularly Women who do not practise BSE
Study
(first author),
country
Age of women
(years)
No. of breast
cancer deaths
a
No. of women
without breast
cancer
No. of breast
cancer deaths
a
No. of women
without breast
cancer
Relative risk or
odds ratio of death
(95% CI, if available)
Cohort studies
Gastrin, 1994, Finland All (X20) 95 28780 FF 0.71 (0.57–0.87)
20–49 24 FF F 0.64
X50 71 FF F 0.74
Holmberg, 1997, USA All 925 176677 1375 271179 1.03 (0.95–1.12)
p39 FF F F 0.95
40–49 FF F F 1.07
50–59 FF F F 1.03
X60 FF F F 1.02
Case–control studies
Muscat, 1992, USA All (unspec.) 251 430 184 457 1.45 (1.15–1.83)
Newcomb, 1991, USA 20–80 168 344 41 89 1.06 (0.70–1.60)
Harvey, 1997, Canada All (40+) 97 1095 121 1091 0.79 (0.59–1.04)
aOr women with advanced breast cancer (Muscat, 1992; Newcomb, 1991). Dashes indicate that the data were not available from the published paper.
Table 3 Clinical trials of BSE; the number of biopsies, breast cancer cases and deaths and the relative risk of dying from breast cancer in women who
practise BSE compared to those who do not
BSE training No BSE training
Study
Age of women
(years) Biopsies
Breast
cancers Deaths
Number
randomised Biopsies
Breast
cancers Deaths
Number
randomised
Relative risk of
death
(95% CI)
Nonrandomised
UK Trial, 1999 All (45–74) FF 661 63373
b FF 1312 127123
b 0.99 (0.87–1.12)
c
(after 16 years) 45–49
a FF 236 FF F 511 F 0.94 (0.80–1.12)
50–54 FF 159 FF F 318 F 0.96 (0.78–1.18)
55–59 FF 189 FF F 388 F 0.98 (0.81–1.19)
60–64 FF 165 FF F 318 F 0.99 (0.81–1.22)
Randomised
China 30–69
(after 5 years) 1788 331 25 133375 945 322 25 133665 1.00 (0.58–1.74)
(after 10 years) 3627 857 135 132979 2398 890 131 133085 1.03 (0.81–1.31)
Russia 40–64
(after 5 years) 662 190 F 60221 467 192 F 60089 F
(after 9 years) 1094 449 99 57712 757 406 97 64759 1.15 (0.87–1.52)
(after 13 years) 1138 493 157 57712 797 446 164 64759 1.07 (0.86–1.34)
aIncludes women from additional cohorts. Dashes indicate that the data were not available from the published paper. Publications: China (Thomas, 1997, 2002) and Russia
(Semiglazov, 1992, 1996, 1999).
bFor the UK trial, this is the number of women invited to attend BSE training or the number that were not (i.e. in the comparison centres).
cAge
adjusted.
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women in different age groups (Tables 1, 2 and 3).
DISCUSSION
Women who practise BSE
Only observational studies of women with breast cancer who were
asked about their history of regular BSE practice consistently
found a difference in breast cancer mortality associated with BSE.
The studies are likely to be affected by several biases – publication
bias, selection bias, recall bias, lead-time bias and length-biased
sampling (there may be a larger proportion of slow-growing
cancers diagnosed in women who practise BSE; slow-growing
cancers tend to have better prognoses). Several studies have shown
that various characteristics that are likely to be associated with
dying from breast cancer were also associated with BSE practice,
but analyses adjusting for the potential effect of such confounding
on mortality were not reported. Women who practised BSE tended
to be younger, premenopausal and of a higher socioeconomic
status (Smith et al, 1980; Feldman et al, 1981; Tamburini et al,
1981; Huguley et al, 1988; Le Geyte et al, 1992; Auvinen et al, 1996).
Much of the reduction in mortality observed in these studies might
therefore be explained by a combination of these and other
confounding factors as well as the aforementioned biases, rather
than a real effect of BSE.
Women who found their cancer during an examination
No evidence of a reduction in mortality was found in women who
reported that they found their cancer during self examination
(Figure 1). There was an indication that there was an effect when
advanced cancer was used as the outcome measure, but the overall
result was not statistically significant (Figure 2).
Women who are taught BSE
The two randomised trials of mortality are unaffected by bias and
both show no effect of BSE on breast cancer mortality, after 5 or 13
years. In the Russian trial, there was an increase in breast cancer
diagnoses in women taught BSE after 9 and 13 years, but this was
not reflected in a decrease in mortality at either time. Both trials
also show that women in the BSE group are much more likely to be
referred for a biopsy. At about 10 years, the overall malignant to
benign biopsy ratio was 1:2.3 in the BSE group and 1:1.3 in the
non-BSE group, indicating that in women who were taught BSE,
there is one extra biopsy in women without cancer for every
diagnosed case of breast cancer.
Despite the initial appeal of regular BSE, the evidence shows that
it is likely to result in a considerable increase in women without
breast cancer who have breast biopsy with its associated anxiety
and counselling, but with no benefit. The two randomised and one
nonrandomised trials were based on about 580000 women and
2344 breast cancer deaths; the conclusions are therefore robust.
Although the two randomised trials were based on BSE training,
the negative results are also, to some extent, applicable to BSE
practice since uptake was high and women reported practising BSE
regularly (every 2 months in the Russian trial and every 4–5
months in the Chinese trial).
Breast self-examination as an alternative to mammography
The results presented here on BSE may have an impact on the
current debate over the use of mammography screening. Despite
clear evidence to the contrary (Wald et al, 1993; Nystrom et al,
1996; IARC 2002), it has been suggested recently that mammo-
graphy screening is not effective in reducing mortality for breast
cancer (Olsen and Gotzsche, 2000, 2001). Breast self-examination
may be considered to be an alternative. The conclusion that
mammography was not worthwhile was based on only one out of
the six existing randomised trials of breast-cancer mortality
comparing mammography with no screening. The other five trials
were rejected on the grounds of perceived differences between the
screened and unscreened groups at baseline. When the one trial
acceptable to the authors was combined with a trial that compared
mammography with clinician examination, the reported relative
risk was 1.04 (95% CI 0.84–1.27). As a result, there has been some
confusion over whether mass mammography screening should
continue. Several groups (Reply to Olsen and Gotzsche, 2000;
Miettinen et al, 2002) have rejected the claim that mammography
is not worthwhile with many valid criticisms of the reported
analysis. Taking the evidence from all six trials, the relative risk is
0.76 (95% CI 0.67–0.87) in women aged X50 years (Wald et al,
1993); a statistically significant 24% reduction in breast cancer
deaths. Mammography screening is recommended to women over
the age of 40 years in the US and 50–64 years in the UK. Without
it, these women currently have no other means of reducing their
chance of dying from breast cancer. Breast self-examination,
perhaps the only other method that could be in widespread use, is
unlikely to be a worthwhile alternative, even as a method of
screening to be used in between mammographic examinations.
The evidence presented here shows that it is ineffective in saving
lives. Women should, of course, still be aware of changes in their
breasts and seek advice if concerned, but being taught BSE and
practising it regularly is no more effective at reducing breast
cancer mortality than finding the tumour by chance.
0.2 0.5 1 2 3 4 5
Relative risk (95% Cl)
Seeking medical advice
Russia (5 years)
Russia (5 years)
China (5 years)
            (9 years)
            (10 years)
            (9 years)
            (13 years)
            (13 years)
Undergoing a biopsy
Diagnosis of breast cancer
Both (5 years)
Both (9 and 10 years)
Russia (5 years)
China (5 years)
China (5 years)
            (10 years)
            (9 years)
            (13 years)
Both (5 years)
Both (9 and 10 years)
Death from breast cancer
            (10 years)
Russia (9 years)
            (13 years)
       UK (16 years)
All three (longest follow-up)
1.64 (1.24−2.18)
1.53 (1.44−1.63)
1.01 (0.90−1.15)
1.09 (0.86−1.38)
1.01 (0.92−1.12)
Figure 3 Trials of BSE training. The rates for specified outcomes are
compared between women invited for BSE training and those who were
not. A test for heterogeneity between the trials yielded a P-value of 0.94 in
relation to the results on mortality.
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